
InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

